BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 8069658)

  • 1. Angiotensin-converting enzyme inhibition and calcium channel blockade both normalize early hyperfiltration in experimental diabetes, but only the former prevents late renal structural damage.
    Perico N; Amuchastegui CS; Malanchini B; Bertani T; Remuzzi G
    Exp Nephrol; 1994; 2(4):220-8. PubMed ID: 8069658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organ specificity of antihypertensive therapy on ocular albumin vascular clearance and albuminuria in the hypertensive diabetic rat.
    Gin T; Joon TL; Panagiotopoulos S; Cooper M; Taylor H; Jerums G
    Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):281-9. PubMed ID: 8603832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
    Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparate effects of angiotensin converting enzyme inhibitor and calcium blocker treatment on the preservation of renal structure and function following subtotal nephrectomy or streptozotocin-induced diabetes in the rat.
    Jackson B; Cubela R; Debrevi L; Whitty M; Johnston CI
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S167-9. PubMed ID: 2455124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic nephropathy in the rat: differing renal effects of an angiotensin converting enzyme inhibitor and a calcium inhibitor.
    Whitty MR; Jackson B
    Diabetes Res; 1988 Jun; 8(2):91-6. PubMed ID: 2852570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of effects of ACE inhibition with calcium channel blockade on renal disease in a model combining genetic hypertension and diabetes.
    Rumble JR; Doyle AE; Cooper ME
    Am J Hypertens; 1995 Jan; 8(1):53-7. PubMed ID: 7734098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
    Ishimitsu T; Honda T; Ohta S; Akashiba A; Takahashi T; Kameda T; Yoshii M; Minami J; Takahashi M; Ono H; Matsuoka H
    Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of combination therapy with a calcium channel blocker and an angiotensin-converting enzyme inhibitor on renal hypertrophy and urinary albumin excretion in diabetic rats.
    Nielsen B; Grønbaek H; Osterby R; Flyvbjerg A
    Exp Diabesity Res; 2003; 4(3):191-9. PubMed ID: 15061647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Passive Heymann nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury.
    Zoja C; Corna D; Bruzzi I; Foglieni C; Bertani T; Remuzzi G; Benigni A
    Exp Nephrol; 1996; 4(4):213-21. PubMed ID: 8983642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of angiotensin-converting enzyme inhibitors in experimental diabetes.
    Anderson S
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S51-4. PubMed ID: 16989065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade on the evolution of spontaneous glomerular injury in male MWF/Ztm rats.
    Remuzzi A; Malanchini B; Battaglia C; Bertani T; Remuzzi G
    Exp Nephrol; 1996; 4(1):19-25. PubMed ID: 8788596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-peptide and captopril are equally effective in lowering glomerular hyperfiltration in diabetic rats.
    Samnegård B; Jacobson SH; Johansson BL; Ekberg K; Isaksson B; Wahren J; Sjöquist M
    Nephrol Dial Transplant; 2004 Jun; 19(6):1385-91. PubMed ID: 15004258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Are all antihypertensive drugs renoprotective?].
    Wolf S; Risler T
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early, but not late therapy with a vasopressin V1a-antagonist ameliorates the development of renal damage after 5/6 nephrectomy.
    Windt WA; Tahara A; Kluppel AC; de Zeeuw D; Henning RH; van Dokkum RP
    J Renin Angiotensin Aldosterone Syst; 2006 Dec; 7(4):217-24. PubMed ID: 17347933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discrepant regulation of QT (QTc) interval duration by calcium channel blockade and angiotensin converting enzyme inhibition in experimental hypertension.
    Klimas J; Vaja V; Vercinska M; Kyselovic J; Krenek P
    Basic Clin Pharmacol Toxicol; 2012 Oct; 111(4):279-88. PubMed ID: 22626243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of angiotensin-converting enzyme inhibition in diabetic rats with reduced renal function.
    Geiger H; Bahner U; Vaaben W; Dammrich J; Heidland A; Luft FC
    J Lab Clin Med; 1992 Dec; 120(6):861-8. PubMed ID: 1453108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of KATP channel blocker U37883A on renal function in experimental diabetes mellitus in rats.
    Vallon V; Albinus M; Blach D
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1215-21. PubMed ID: 9732381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphometric detection of incipient glomerular lesions in diabetic nephropathy in rats. Protective effects of ACE inhibition.
    Sassy-Prigent C; Heudes D; Jouquey S; Auberval D; Belair MF; Michel O; Hamon G; Bariety J; Bruneval P
    Lab Invest; 1995 Jul; 73(1):64-71. PubMed ID: 7603042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor-alpha gene expression in diabetic nephropathy: relationship with urinary albumin excretion and effect of angiotensin-converting enzyme inhibition.
    Navarro JF; Milena FJ; Mora C; León C; Claverie F; Flores C; García J
    Kidney Int Suppl; 2005 Dec; (99):S98-102. PubMed ID: 16336586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.